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Abstract. A prospective study was undertaken in 12 hae-
modialysed patients successively treated on five new as
well as re-used dialyser membranes, that is cuprophane,
cellulose acetate, polysulphone, polycarbonate, and
polyacrylonitrile. A significant reduction of neutrophils
occurred with every membrane during their first use,
which improved only with cuprophane upon re-use.
Thrombocytopenia was noted only when neutropenia
reached very low values. Monocyte reduction occurred on
cuprophane, cellulose acetate and polycarbonate, but did
not improve during second use. C3d accumulation paral-
leled the time course of neutropenia only with cuprophane
and cellulose acetate. Plasma collected at the extreme of
neutropenia induced aggregation of control and predialy-
sis cells, but did not aggregate autologous dialysed
neutrophils collected at 5 min. Our data indicate that the
mechanism linking complement activation to neutropenia
is probably triggered by more than one factor.
Key words: Haemodialysis; Neutropenia; Thrombocyto-
penia; Monocytopenia; Complement; Aggregation
Introduction
A marked neutropenia occurs immediately after the start
of a haemodialysis session [1]. Although contact between
blood and dialyser membrane is necessary to induce this
phenomenon, almost all the circulating neutrophils disap-
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Nephrology, CHUV, 1011 Lausanne, Switzerland.
pear before 20% of the blood has actually circulated
through the dialyser [1,2]. This neutropenia is mainly due
to margination of the neutrophils in the pulmonary capil-
laries [3] and is thought to be a consequence of dialyser-
associated activation of the complement system through
the alternative pathway [4-7]. One of the fragments of this
complement cascade, the C5a, was suggested to play the
major role in this phenomenon by triggering aggregation
of the circulating polymorphonuclear leucocytes (poly-
morph) [8,9]. Cells return to circulation well before the
end of dialysis, despite the persisting complement acti-
vation [10]. The transience of the pulmonary leukostasis
has been attributed to an acquired refractoriness of
granulocytes to repeated complement stimulation most
likely resulting from down-regulation of membrane
receptors for C5a desarg [11].
However, not only plasmatic but also cellular factors
are able to produce aggregation of neutrophils in vitro
and in vivo [12,13]. Indeed, neutrophil cationic proteins
and platelet activating factor released from polymorph
and platelets have been shown to induce an aggregating
activity which could lead to granulocyte sequestration
[14-16]. More recently it has been proposed that comp-
lement activation in vivo is associated with up-regulation
of neutrophilic C3b receptors, indicating that this cellular
response is a physiological mechanism by which this cell
can augment its capacity for responding to C3b opsonised
material [17]. Another recent finding has identified a
phagocyte-surface glycoprotein called Mo 1, which
appears to be involved in neutrophil adhesion and whose
expression is increased and coincides with the maximum
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Table 1. Characteristics of the patients
Initials
AF
MB*
MLD
SP
GS
GP
DM
MJ
ES
NS
ccK.R
Age
47
78
60
59
53
70
49
51
80
64
65
64
Sex
f
f
r
rf
m
m
f
m
f
m
m
Renal disease
Chronic interstitial nephritis
Chronic interstitial nephritis
Chronic glomerulonephritis
Nephroangiosclerosis
Analgesic nephropathy
Analgesic nephropathy
Renal polycystic disease
Renal polycystic disease
Analgesic nephropathy
Chronic interstitial nephritis
Nephroangiosclerosis
Analgesic nephropathy
Duration
ofHD
(months)
109
101
88
62
21
18
15
13
13
6
2
2
Heparin
start/
hourly
2500/250
5000/375
4000/750
2500/250
2000/500
4000/1000
5000/250
2000/250
3000/700
5000/500
2500/500
3000/500
*Died after first month of study
reduction in neutrophil count during dialysis on a new
cuprophane membrane [18]. It was suggested that this
increased expression of Mo 1 could provide a mechanism
for initiating sequestration of neutrophils and neutropenia
during haemodialysis.
Neutropenia and complement activation have been
shown to be attenuated on new non-cellulosic membranes
[19-25] and on re-used cuprophane [26-30], but the effect
of re-use has never been systematically studied on
non-cellulosic membranes.
The above-described parameters have now become the
most investigated aspects of the biocompatibility of dia-
lyser membranes [31]. In order to evaluate the biocom-
patibility of five different membranes and the effect of
their re-use, and to gain a better insight into the mechan-
ism of haemodialysis-related neutropenia, a prospective
crossover study was undertaken in 12 patients successively
dialysed on cuprophane, cellulose acetate, polysulphone,
polycarbonate, and polyacrylonitrile. Simultaneous deter-
minations of white blood cell (WBC) counts, platelet
counts, the C3d complement degradation product, and
the aggregating capacity of dialysed neutrophils were
performed throughout the dialysis session.
Methods
Patients
Twelve patients (Table 1), seven females and five males,
from 47 to 80 years old, gave informed consent to partici-
pate in this study. All patients had been dialysed for 2 to
109 months, with a mean duration of 32 months. Dialysis
sessions were of 3 x 3 h/week. None of these patients were
diabetic, had any acute illness, nor took corticosteroids
during the study period. Patient MB died after the first
month of study owing to a cerebral vascular accident at
the age of 78.
Haemodialysis Procedure
Two cellulosic and three synthetic membranes were tested
successively during first use (I) and 48 h later during
second use (II). The investigations were done monthly
and, in the intermediate period the patients were dialysed
on cuprophane which was also reprocessed with formalin
3% (one new filter per week).
All 12 patients began the study with cuprophane
hollow-fibre dialyser, which was their usual membrane
(CF 1511; Travenol, USA; surface area 1.3 m2). At each
subsequent month the following dialysers were tested:
cellulose acetate hollow fibre dialyser (cellulose acetate
170; Travenol, USA; surface area 1.7 m2), polysulphone
hollow fibre (F60; Fresenius, Germany; surface area
1.3 m2), polycarbonate plate membrane (Lundia Pro 5;
Gambro Lundia, Sweden; surface area 1.1 m2), and
finally polyacrylonitrile plate membrane (Biospal 2400 S;
Hospal, France, surface area 1.0 m2).
The blood flow rate was maintained at 250-300 ml/min
from an internal arteriovenous fistula and the dialysate,
which contained acetate, had a flow rate of 500 ml/min in
a single-pass mode. Heparin was administered at a dose
of 2000-5000 U at the start and 250-1000 U hourly by
continuous infusion.
Dialyser Re-use
A semi-automated method was applied as follows: back
filtration was carried out with tap water treated by reverse
osmosis, and the complete blood removal was checked
visually. The dialyser was filled with 3% formalin in both
the dialysate and the blood compartments, and subse-
quently stored at 4°C. According to the manufacturer's
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instructions, an initial rinsing with 1 % hypochlorite was
carried out exclusively for polyacrylonitrile before con-
tinuing the above described re-use method. Immediately
prior to the next use, the formalin was washed out for
20 min from the blood compartment with 3000 ml saline,
and simultaneously from the dialysate compartment with
dialysate at a flow of 500 ml/min.
Sample Collection for Blood Cell Counts and
Complement Measurements
During each dialysis session studied, 2 ml whole blood
was initially obtained from the patient's arteriovenous
fistula (predialysis, time 0). Four additional blood
samples were drawn from the venous (outflow) line of the
dialyser at 5, 15, 60 min, and at the end of the dialysis
session. The blood samples were immediately placed into
test tubes containing 3.3 mg potassium-ethylenediamine-
tetraacetic acid (K-EDTA). During the whole study all
the samples were taken by the same person in order to
improve the time reliability. The WBC counts were
performed using an automated haematology analyser
(Sysmex CC-800), and differential counts of granulocytes
as well as monocytes and platelets counts were carried out
manually through the study by the same person.
Complement Measurements
The level of C3d generated by activation of the comp-
lement system was measured in a two-step procedure [32].
Native C3 and high-molecular-weight fragments C3b and
C3c were precipitated with polyethylene glycol. The C3d-
containing supernatant was assayed by single radial
immunodiffusion (RID) with anti-C3d antiserum (Behr-
ing Werke AG). C5a desarg antigen was performed with a
commercial radioimmunoassay kit (Upjohn Co, Kalama-
zoo, Michigan).
Granulocyte Isolation
Three millilitres of blood at times 0 and 60 min, and 6 ml
at times S and 15 min were collected in heparinised tubes
(10 U/ml) from the outflow line of the dialyser. Purified
preparations of polymorphonuclear leucocytes were
obtained in a single centrifugation step on discontinuous
density Percoll gradients (Pharmacia, Uppsala, Sweden),
according to a published technique [33] which was slightly
modified. Isotonic Percoll was obtained by diluting 9 vol-
umes of Percoll with a volume of 1.5 M NaCl. Percoll
76% and 60% (vol/vol) were prepared by further diluting
the isotonic Percoll in Ca- and Mg-free Hanks balanced
salt solution (HBSS). The discontinuous gradient was
775
produced by overlaying 3 ml 76% Percoll with 3 ml 60%
Percoll. Three millilitres heparinised undiluted blood was
layered on top of the gradient and the tube was centri-
fuged at 350 G for 20 min at 20°C. After withdrawal of the
plasma layer, which was kept on ice until use, the granulo-
cyte layer was carefully aspirated with a Pasteur pipette
and washed once in Ca2+- and Mg2+-free HBSS at 350 G
for 10 min at 4°C. Contaminating red cells were removed
by hypotonic lysis [29]. The cells were resuspended in
Ca2+- and Mg2+-free HBSS containing glucose (5 mM)
and human serum albumin 0.5% (HBSS/HSA) to a con-
centration of 2 x 107 polymorph/ml. The purity of the
cells was assessed by cyto-centrifugation of the purified
preparations and staining with May Grunwald-Giemsa.
It was found that more than 93% of the cells were neutro-
phils. The polymorph yield calculated for dialysed poly-
morphs during dialysis on cuprophane, first use at time 0,
5, 15 and 60 min was 75.5% ±2.9 (mean±SEM);
70.1 % ± 5.9; 64.3% ±8.2 and 70.1 % ± 6.2 respectively. It
was not significantly different from the yield of control
polymorphs: 69.7% ±6.4.
Granulocyte Aggregometry
Aggregometry was performed according to a modifi-
cation of the Craddock et al method [8], with a standard
platelet aggregometer (H. Upchurch and Co, Leicester,
England). To a siliconised cuvette containing a siliconised
stirring bar revolving at HOOr.p.m., 200 ul HBSS/HSA
containing 1.2 mM Ca2+, 1.0 mM Mg2+ and 5 ng/ml
cytochalasin B (cyto B) (Sigma), 250 ul of cell suspension
was added. After a 2-min delay to allow warming of the
cells, 50 ul of autologous dialysed plasma or zymosan-
activated plasma was added. The resulting change in light
transmission was recorded. Zero per cent light trans-
mission was calibrated with the test suspension, and
100% was calibrated with cell suspension diluted 1:1 with
HBSS/HSA. The increment in light transmission between
the initial cell preparation and the dilution was set at
18 cm.
Zymosan (Sigma) was prepared as previously described
[34]. Zymosan activated plasma was obtained by incubat-
ing 40 mg zymosan for 30 min at 37°C in 5 ml plasma
containing 10 U heparin per ml. After centrifugation of
the particles, zymosan-activated plasma was frozen in ali-
quots of — 80°C for not more than one month and thawed
on the day of use. Cyto B was stored as a stock solution
in dimethylsulphoxide (DMSO) at a concentration of
1 mg/ml at 4°C and diluted in HBSS/HSA for use.
Statistics
Unless otherwise stated, statistical analysis was carried
out using the Wilcoxon signed-rank test for matched
pairs.
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Results
Effect of New and Re-used Membranes on Neutrophil
Counts
A significant reduction in the number of neutrophils
occurred on every filter studied during their first use
(Fig. 1). When neutropenia was greatest, only 6± 1% of
predialysis polymorphs remained in circulation with
cuprophane, 45 ± 11 % with polycarbonate, 49 + 9% with
cellulose acetate, 78 + 4% with polysulphone and
83 ± 12% with polyacrylonitrile. Maximum neutropenia
appeared as early as 5 min on cellulose acetate, polysul-
phone and polyacrylonitrile, and at 15 min on cupro-
phane and polycarbonate. A significant rebound at the
end of dialysis was observed only with cuprophane.
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Monocyte Count
Although the time course of monocyte reduction was
comparable to that of neutrophils, important differences
were observed, depending on the membrane (Table 3).
Monocytopenia was substantial with cuprophane, but
improved upon re-use. With cellulose acetate and
polycarbonate, monocytopenia remained the same upon
re-use and was of a similar extent to the neutropenia.
Polysulphone showed no significant reduction of mono-
cytes on first use, but only on second use (47%). Finally,
polyacrylonitrile produced a substantial monocytopenia
during first use (62%) whereas only a slight neutrophil
fall was evidenced. This monocytopenia completely
disappeared upon re-use of the membrane.
Platelet Count
150
I
M
too
50
• Cuprophane
• Cellulose acetate
* Polysulphone
• Polycarbonate
• Polyacrylonitrile
15 60
TIME (min)
End
Fig. 1. Haemodialysis neutropenia during the first use of different
dialyser membranes. For clarity, SEM are omitted but can be found in
Table 2.
Upon re-use of the membranes (Table 2), neutropenia
with cuprophane was improved from 6% to 66%, but
there was no improvement with re-use of cellulose acetate,
polysulphone, polycarbonate or polyacrylonitrile. Maxi-
mum neutropenia appeared at the same time as during
first use for all membranes except for cellulose acetate and
polysulphone, which switched their maximum neutro-
penia from 5 to 15 min. At the end of dialysis cuprophane,
cellulose acetate and polycarbonate showed a significant
rebound of the polymorph count.
During the 5 months of the study the neutrophil counts
at time 0 did not show any significant variation: (cupro-
phane 4.2 + 0.5; cellulose acetate 4.4 + 0.7; polysulphone
4.1+0.3; polycarbonate 4.6 ±0.5; polyacrylonitrile
4.1+0.6)xl09/l.
During first use a significant reduction in thrombocytes
occurred only with cuprophane (Table 4). However,
during re-use a significant thrombocytopenia occurred
with cellulose acetate and polycarbonate. It started at
5 min and continued to decrease until the 15th min. All
the values had returned to baseline at 60 min and
remained stable till the end of the dialysis.
Complement Activation
The kinetics of the generation of C3d showed a significant
increase by 5 min for all the membranes tested during first
and second use except for polyacrylonitrile (Fig. 2a-«).
Interestingly, C3d paralleled the time course of neutro-
penia during the early phase of haemodialysis on cupro-
phane and cellulose acetate only. On the other membranes,
C3d accumulated in a striking manner at 60 min and also
at the end of dialysis. Finally re-use produced no improve-
ment of C3d values at maximum neutropenia except on
cuprophane. In the plasma of two patients chosen at ran-
dom, signs of complement activation were investigated by
measuring changes in plasma C5a desarg during dialysis
with first use cuprophane, first use cellulose acetate, and
polycarbonate first and second use. An indicative and
positive correlation was found between C5a and C3d
(R 0.57; 0.79; 0.45 and 0.53 respectively), suggesting that
accumulation of C3d follows the same kinetics as C5a
desarg during haemodialysis.
Relationship Between Granulocytopenia and Comp-
lement Activation
By comparing the accumulation of C3d when neutropenia
was most marked, striking differences were observed
Table 2. Evolution of neutrophil count during first and second use of dialyser membranes
Time Cuprophane Cuprophane Cellulose Cellulose
(min) I II acetate I acetate II
Polysulphone Polysulphone polycarbonate Polycarbonate Polyacrilonitrile
I II I II I
Polyacrilonitrilc
II
a
"5
5
15
60
End
75±4
**
6±l
**
IO6±8
152 ± 22
84±2
*
66 ±12
1I2±9
I28±I6
49 ±9
**
63±6
*•
1I5±9
121 ± 15
52±8
• #
36 ±8
**
111 ±8
127+17
78 + 4
••
80±7
**
U2±IO
119+14
6I±9
*
58 + 6
**
94±8
IIO±1O
75±12
*•
45 ±11
**
93±12
111 ± 12
6 l ± l l
*•
32 ±23
**
95±" 12
127±17
S3 ±12
86±I4
*
IOO±I4
111 ± 20
74 ±12
»* •••
87±14
*
103 ±14
IO4±I5
9
iz
stropt
a_
Neutrophil count on first (I) and second (II) use in % of predialysis value: mean ±SEM
Initial values were (polymorphx lO'/l): cuprophane 1,4.2 ±0.5; cuprophane II, 4.1 ±0.4; cellulose acetate 1,4.4+0.7; cellulose acetate II, 4.3+0.4; polysulphone 1,4.1 +0.3; polysulphone II, 3.7±0.5;
polycarbonate 1,4.6±0.S; polycarbonate II, 4.3 ±0.5; polyacrylonitrile 1,4.1 ±0.6; polyacrylonitrile 11,4.3 ±0.6
*0.02 < P^O.05 vs predialysis values
**f^0.01 vs predialysis values
•*V=0.07 (CU) and P=0.004 (PAN)
Table 3. Evolution of monocyle count during first and second use of dialyser membranes
Time
(min)
5
15
60
End
Cuprophane
1
89 ±17
I4±3
*•
87 ±17
1I1±I9
Cuprophane
II
57±12
*
47±10
• * *«*
68 ±10
*
98±I7
Cellulose
acetate I
63±I7
48 ±9
*»
115±17
I2O±I7
Cellulose
acetate II
56+10
•
32±8
••
85±19
108±19
Polysulphone
I
79±13
79±15
U9±I7
104 + 21
Polysulphone
II
67±16
47 ±12
• •
112 ± 32
9O±I9
polycarbonate
I
72+13
S5±13
*
81 ±17
104±21
Polycarbonate
II
82±I8
30+9
*
84±2I
118±3O
Polyacrilonitrile
62 + 12
*
58±I2
79±17
85±15
Polyacrilonitrile
11
U9±19
***
109 ±19
136±24
95±I7
Monocyte count on first (1) and second (II) use in % of predialysis value: mean ±SEM
Initial values were (monocytes x 109/l): cuprophane 1,0.53 ± 0.11; cuprophane II, 0.60 ± 0.09; cellulose acetate 1,0.46± 0.06; cellulose acetate II, 0.59 ± 0.09; polysulphone 1,0.48 ±0.08; polysulphone
II, 0.58±0.08; polycarbonate 1,0.47±0.08; polycarbonate II, 0.44±0.13; polyacrylonitrile 1,0.52±0.09; polyacrylonitrile II, 0.42±0.07
•0.02 < P < 0.05 vs predialysis values
••P^O.01 vs predialysis values
***P=0.07(CV)and />=0.004(PAN) /^O.Ocomparingsecond to first use
Tible 4. Evolution of thrombocyte count during first and second use of dialyser membranes
Time
(min)
5
15
60
End
Cuprophane
I
94 ±15
88±13
IOO±I4
1O4±I6
Cuprophane
II
87+ 15
96±16
89±I3
9O±I8
Cellulose
acetate I
113 ± 16
1I6±I7
131 ± 19
I16±9
Cellulose
acetate II
85±13
85±I3
92±I2
95+16
Polysulphone
I
98±ll
98+11
I02±ll
103±ll
Polysulphone
11
97+14
96±I5
99±I4
100±15
polycarbonate
I
97 + 11
97±ll
99±10
I02±9
Polycarbonate
II
9I±11
87±11
95±ll
99±I2
Polyacrilonitrile
I
99±ll
104+10
102±ll
102± 10
Polyacrilonitrile
II
99±l l
99±l l
98±10
101 ±10
Thrombocyte count on first (I) and second (II) use in % of predialysis value: mean+.SEM
Initial values were (thrombocytes x 109/l): cuprophane I, 200 + 27; cuprophane II, 239±38; cellulose acetate I, 152± 19; cellulose acetate II, 195 + 28; polysulphone 1, 182±24; polysulphone II,
I78±25; polycarbonate I, I76± 18; polycarbonate II, 172± 19; polyacrylonitrile I, I68±20;polyacrylonitrile II, I58±I7
•0.02 < P < 0.05 vs predialysis values
vs predialysis values
O
X
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Fig. 2 (a-e). Kinetics of C3d accumulation during haemodialysis. Values
(mean ± SEM) represent the increase of C3d compared to time 0 values.
5; •*/>$0.0l; vs time0 values.
between membranes (Fig. 3). A similar increase of C3d
appeared with cuprophane and cellulose acetate during
first use, whereas the extent of the neutrophil reduction
with cuprophane (94%) was almost twice as large as that
observed on cellulose acetate (51%) (P< 0.001 evaluated
using paired t-test as for all the subsequent comparisons
of this paragraph). Polycarbonate and polysulphone
activated complement to the same extent, whereas the
neutrophil reduction with polycarbonate was more than
twice as large as that with polysulphone (P < 0.002). These
comparisons between polycarbonate and polysulphone
were again observed on second use (/>< 0.002). Further-
more, the neutrophil reductions during second use were
the same with cellulose acetate as with polycarbonate, and
were the same with polysulphone as with polyacryloni-
trile, but the C3d accumulation in cellulose acetate was
twice that of polycarbonate (P<0.02) and three times
larger with polysulphone than with polyacrylonitrile
(P < 0.02). Finally, when comparing first and second use it
appears that complement activation at the time of maxi-
mum neutropenia was reduced only with cuprophane.
Time Course of Dialysed Polymorph Aggregation
Neutrophils isolated at different times during haemo-
dialysis with cuprophane, cellulose acetate, polysulphone,
and polyacrylonitrile were assessed for their ability to
aggregate in response to their plasma collected at the
extreme of neutropenia (15 min for cuprophane, cellulose
acetate, and polysulphone and 5 min for polyacryloni-
trile) (Fig. 4). Time 0 dialysed polymorphs and control
polymorphs responded equally well to the respective plas-
mas collected at the maximum neutropenia for each mem-
brane, indicating that there is no defect in polymorphs
from dialysed patients at the start of dialysis. However,
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Fig. 3. Maximum neutropenia and related complement activation.
Values are mean ± SEM.
Owing to the small amount of polymorphs collected at
the maximum neutropenia, it was only possible to
measure this aggregating activity with the polysulphone
15-min dialysed polymorphs. The aggregating response
had already returned to time 0 values. Aggregating
capacity at 60 min remained impaired on cuprophane and
polyacrylonitrile dialysed cells, but on polysulphone a
return to normal values and on cellulose acetate a trend
towards normal values was observed.
To determine whether the alterations in neutrophil
aggregometry responses were related to C5a, zymosan-
activated plasma containing a high amount of activated
complement (7.72 ± 1.25 mg C3d. 100 ml"1, « = 4) was
used as the aggregating stimulus on cells collected during
cuprophane and cellulose acetate dialysis. With cupro-
phane, cells collected at 5 min retained their time 0 aggre-
gating responses, but cells isolated at 60 min showed an
impaired response to zymosan-activated plasma
(/><0.02). With cellulose acetate, cells isolated at 5 and
60 min showed a similar aggregation to time 0 cells in
response to zymosan-activated plasma.
there was no correlation between the degree of aggre-
gation observed and the amount of C3d accumulated
within the plasma used for stimulation.
80
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S «,
^ 3 0
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0
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Fig. 4. Aggregation responses of dialysed polymorphs collected at differ-
ent times of dialysis. Control polymorphs (C) ^ , and dialysed poly-
morphs D, from the different membranes were stimulated with their
autologous plasma collected at the maximum of neutropenia, i.e. 15 min
for cuprophane, cellulose acetate and polysulphone and 5 min for
polyacrylonitrile. Symbol II; represents the stimulation with zymosan-
activated plasma of cuprophane- and cellulose acetate-dialysed
polymorphs. In brackets the number of patients investigated on each
membrane. Bars denote the SEM and */>s£0.03 vs time 0 dialysed
polymorphs. Statistical significance was evaluated with the paired t-test.
Cells collected after 5 min of dialysis showed a striking
reduction in their aggregating capacity (Figs 4, 5). The
aggregation responses at 5 min compared to time 0 were
46%, 29%, 59% and 39% for cuprophane, cellulose
acetate, polysulphone and polyacrylonitrile respectively.
Discussion
The present study of five membranes and their re-use
enables a comparative evaluation of membrane biocom-
patibility, based on white blood cells, platelet counts and
complement activation as parameters. The comparison is
valid since all five membranes were studied successively
with the same patients. A rough classification can then be
proposed: on first use cuprophane, as expected, appears
the least biocompatible; in contrast polysulphone and
polyacrylonitrile seem to possess the highest biocompati-
bility properties, while cellulose acetate and polycarbonate
are in an intermediate place.
Re-use has been claimed to be associated with
improved neutropenia and complement activation
[23,26-30]. These studies, however, concerned exclusively
cuprophane membranes usually processed with formalin.
This observation was confirmed in our study. On the
contrary, cellulose acetate, as shown by others [30], and
polysulphone or polycarbonate did not show any im-
provement of neutropenia, monocytopenia and comp-
lement activation upon their second use. Polyacrylonitrile
showed an even more marked decrease of the slight neu-
trophil reduction from 83% to 74% on second use (after
hypochlorite rinsing), but monocyte counts remained
unchanged and no significant complement activation was
evidenced. The beneficial effect of re-use on cuprophane
has been attributed to a protective protein coating of the
dialyser surface during its first use. This 'protein cake' is
thought not to be removed by the usual re-use technique
enabling the membrane to become more biocompatible
on second use.
Haemodialysis-induced Neutropenia
ZAP
plasma added | f
TI ME 60 min PMN TIME S min PMN Tl ME 0 min PMN
Fig. 5. Aggregating activity of cellulose acetate dialysed polymorphs
induced by autologous 1 S-min plasma and zymosan-activated plasma.
Furthermore, a fixation of C3b on the surface of cupro-
phane during first use, blocking complement-activating
sites has been demonstrated [27]. Re-use of this 'C3b-
coated' dialyser was then associated with only modest
complement activation and haemodialysis neutropenia.
Tn our study the absence of improvement of neutropenia
and complement activation implies that these protective
mechanisms described for cuprophane do not apply to
modified cellulose and synthetic membranes. The reduc-
tion of polymorphs upon re-use with polyacrylonitrile
could be attributed to the reprocessing technique, since
hypochlorite has been shown to remove the protective
protein coating [29], especially C3b [21].
Either the plasma proteins and/or C3b were unble to be
fixed on the membrane or the re-use technique was more
stringent for cellulose acetate, polysulphone, polycarbo-
nate, and polyacrylonitrile than it was for cuprophane.
Whether the re-use technique removes the protein coating
or even damages the membrane, or whether different
membrane hydraulic properties play a role, will necessi-
tate further investigation. Thus, when re-used, the five
membranes tested modified their biocompatibility, bring-
ing cuprophane to the level of polysulphone and polyac-
rylonitrile, whereas cellulose acetate and polycarbonate
remained intermediate.
Complement activation has been closely linked to neu-
tropenia soon after the initiation of a haemodialysis
session [7]. More recently, measurement of complement
fragment C3d has been shown to be an appropriate
cumulative marker of complement activation during
haemodialysis [35]. However C3d might underestimate
activation events, since C3bi, which contains the C3d
epitope, has been shown to be membrane bound on
cuprophane [25]. It serves only as a distant marker of
complement activaion when compared to C3a or Csa, but
its longer half-life makes it a more stable index.
In addition, the positive correlation observed between
C3d accumulation and C5a desarg suggests that these two
indicators of complement activation follow the same
781
kinetics, as also demonstrated by others [36,37], thus re-
flecting the same in vivo phenomenon. Our results show
that complement was related to the neutropenia, but that
it participated in a quantitatively different way with each
membrane. Indeed, for a relatively low complement acti-
vation there was a severe neutrophil reduction with one
membrane (polycarbonate II), whereas the same neutro-
phil change corresponded to a much greater complement
activation with another membrane (cellulose acetate II).
Despite identical complement activation for cuprophane I
and cellulose acetate I, there was a large difference in
neutropenia.
These discrepancies suggest that complement is prob-
ably not the only factor leading to neutropenia.
Thrombocytopenia only appeared when neutropenia
reached very low values as seen during first use of cupro-
phane and second use of cellulose acetate and polycarbo-
nate. In contrast to a recent study [38], this cellular event
did not correlate with the degree of complement acti-
vation as measured by the C3d RID method. Indeed,
thrombocytopenia could not be detected during the first
use of cellulose acetate and polycarbonate despite the fact
that complement was activated to the same extent as dur-
ing their second use when the greatest thrombocytopenia
was noted. Monocytes were affected in a somehow differ-
ent way, and again their reduction did not correlate with
the degree of complement activation.
These observations support the idea that the different
functional modifications of the cells depend both on the
cell type and the dialysis membrane.
To better understand the intimate mechanisms leading
to neutropenia, the functional activity of dialysed poly-
morphs were investigated. The aggregation of granulo-
cytes seems to be the final step leading to pulmonary
sequestration [3]. The present study on aggregation was
undertaken not only to demonstrate complement acti-
vation in dialysed plasma as previously proposed [39], but
also to evaluate the aggregating capacity of isolated dia-
lysed polymorphs especially during the very early phase of
dialysis. Plasma collected at the extreme of neutropenia
induced aggregation of control cells and of predialysis
polymorphs, but to our surprise this same activated
plasma did not aggregate autologous polymorphs col-
lected at 5 min. This phenomenon was observed with all
the membranes studied, even in the absence of severe
neutropenia. In contrast, these polymorphs retained their
aggregating responses to the higher concentration of
complement present in zymosan-activated plasma which
might well overcome the refractoriness of these cells.
These results could be consistent with the notion of down-
regulation of cellular responses to complement as
described for dialysed cells collected 2 h after the onset of
dialysis [11,40]. However, there was no correlation
between the degree of C3d accumulation and the aggrega-
tion activity of the dialysed plasma tested on control and
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predialysis polymorphs. After 60 min of dialysis poly-
morphs were still unresponsive to plasma collected when
neutropenia was extreme. This was true not only with
cuprophane—a membrane with a high stimulatory power
of complement—but also with polyacrylonitrile, with the
lowest capacity of activating complement. In fact poly-
morphs remained unresponsive only on membranes
where the circulating complement was still significantly
activated at 60 min. Some of these discrepancies could be
explained by the behaviour of the dialysis membrane
toward complement. It has been shown that C3a desarg
and C5a des arg are adsorbed on polyacrylonitrile [6].
It has also been demonstrated that circulating poly-
morphs contain a subpopulation of approximately 20%
which show abnormal adherence, chemotaxis, phago-
cytosis, and defective ability to form Fc rosettes [41]. This
functionally defective population has been reported to
predominate in the circulation after 15-20 min of haemo-
dialysis with cuprophane or injection of C5a desarg [42].
Furthermore, neutrophils harvested at the maximum
neutropenia during cuprophane and polycarbonate dialy-
sis were unable to respond equally well to opsonised
zymosan or other soluble stimuli [43,44]. The mechanisms
by which these cells become functionally defective is at
present unknown. It is possible that activated complement
has decreased the ability of these cells to respond to a
subsequent stimulation through a process of stimulus-
specific desensitisation [45]. Indeed, polymorphs exposed
to C5a were deactivated concomitantly to an increased
number of f-Met-Leu-Phe receptors [46]. An increased
number of polymorph C3b receptors were also observed
during haemodialysis on cellulosic membrane [17],
which could explain the metabolic defect in response to
opsonised zymosan. This might partly explain the differ-
ent behaviour of dialysed polymorphs in response to
aggregating stimuli.
However, the discrepancies between the degree of com-
plement activation and leukopenia on one hand and the
aggregating behaviour of 5-min dialysed polymorphs on
the other indicate that other mechanisms could play a role.
Since the cells leaving the filter before the maximum neu-
tropenia do not respond, they will probably not be the cells
aggregating in the lung capillaries. These observations
suggest that a direct cell-membrane interaction should be
considered as an additional or alternative mechanism.
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